Micro-robotic percutaneous targeting of type II endoleaks in the angio-suite
-
Published:2024-05-29
Issue:8
Volume:19
Page:1489-1494
-
ISSN:1861-6429
-
Container-title:International Journal of Computer Assisted Radiology and Surgery
-
language:en
-
Short-container-title:Int J CARS
Author:
Widmann GerligORCID, Deeg Johannes, Andreas Frech, Josef Klocker, Feuchtner Gudrun, Freund Martin
Abstract
Abstract
Purpose
Endovascular aneurysm repair has emerged as the standard therapy for abdominal aortic aneurysms. In 9–30% of cases, retrograde filling of the aneurysm sac through patent branch arteries may result in persistence of blood flow outside the graft and within the aneurysm sac. This condition is called an endoleak type II, which may be treated by catheter-based embolization in case of continued sac enlargement. If an endovascular access is not possible, percutaneous targeting of the perfused nidus remains the only option. However, this can be very challenging due to the difficult access and deep puncture with risk of organ perforation and bleeding. Innovative targeting techniques such as robotics may provide a promising option for safe and successful targeting.
Methods
In nine consecutive patients, percutaneous embolization of type II endoleaks was performed using a table-mounted micro-robotic targeting platform. The needle path from the skin entry to the perfused nidus was planned based on the C-arm CT image data in the angio-suite. Entry point and path angle were aligned using the joystick-operated micro-robotic system under fluoroscopic control, and the coaxial needle was introduced until the target point within the perfused nidus was reached.
Results
All punctures were successful, and there were no puncture-related complications. The pre-operative C-arm CT was executed in 11–15 s, and pathway planning required 2–3 min. The robotic setup and sterile draping were performed in 1–2 min, and the alignment to the surgical plan took no longer than 30 s.
Conclusion
Due to the small size, the micro-robotic platform seamlessly integrated into the routine clinical workflow in the angio-suite. It offered significant benefits to the planning and safe execution of double-angulated deeply localized targets, such as type II endoleaks.
Funder
University of Innsbruck and Medical University of Innsbruck
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Erbel R, Aboyans V, Boileau C, Bossone E, Di Bartolomeo R, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwöger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, Von Allmen RS, Vrints CJM, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol Ç, Fagard R, Ferrari R, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Czerny M, Deanfield J, Di Mario C, Pepi M, Taboada MJS, Van Sambeek MR, Vlachopoulos C (2014) 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. the task force for the diagnosis and treatment of aortic diseases of the European society of cardiology (ESC). Eur Heart J 35:2873–2926. https://doi.org/10.1093/EURHEARTJ/EHU281 2. Isselbacher EM, Preventza O, Black JH, Augoustides JG, Beck AW, Bolen MA, Braverman AC, Bray BE, Brown-Zimmerman MM, Chen EP, Collins TJ, DeAnda A, Fanola CL, Girardi LN, Hicks CW, Hui DS, Jones WS, Kalahasti V, Kim KM, Milewicz DM, Oderich GS, Ogbechie L, Promes SB, Ross EG, Schermerhorn ML, Times SS, Tseng EE, Wang GJ, Joseph Woo Y (2022) 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American heart association/American college of cardiology joint committee on clinical practice guidelines. Circulation 146:E334–E482. https://doi.org/10.1161/CIR.0000000000001106 3. Ozdemir BA, Chung R, Benson RA, Mailli L, Thompson MM, Morgan R, Loftus IM (2013) Embolisation of type 2 endoleaks after endovascular aneurysm repair. J Cardiovasc Surg (Torino) 54:485–490 4. Sidloff DA, Stather PW, Choke E, Bown MJ, Sayers RD (2013) Type II endoleak after endovascular aneurysm repair. Br J Surg 100:1262–1270. https://doi.org/10.1002/BJS.9181 5. Chung R, Morgan RA (2015) Type 2 endoleaks post-EVAR: current evidence for rupture risk, intervention and outcomes of treatment. Cardiovasc Intervent Radiol 38:507–522. https://doi.org/10.1007/S00270-014-0987-X
|
|